FIELD: medicine.
SUBSTANCE: invention relates to the technology of creating a new medical product in the form of rectal suppositories of a wide spectrum of action based on interferon for treating infectious-inflammatory diseases. Suppository is prepared in two stages, first one – 0.01–1 mg/g of sulphite or sodium metabisulphite, 5–30 mg/g of ascorbic acid, 10–30 mg/g of sodium ascorbate, 0.05–0.2 mg/g Trilon B, 0.05–0.2 mg/g Polysorbate 80 and purified water from oxygen; 50,000-5,000,000 IU/g of interferon are introduced into the produced mixture and sterilized by filtration, at the second stage – 30–100 mg/g α-tocopherol, 700–800 mg/g of Witepsol H15 and Witepsol W35 are melted at 35–45 °C and intensely stirred, raising temperature to 70–120 °C, then mixture is cooled to 32–35 °C and combined with intense stirring with a mixture of the first stage, preheated to 32–35 °C, after that suppositories are molded.
EFFECT: medical product in the form of rectal suppositories and a method for preparing it are proposed.
2 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
RECTAL SUPPOSITORIES AND METHOD FOR PREPARATION THEREOF (OPTIONS) | 2017 |
|
RU2674029C1 |
ANTIVIRAL AGENT IN LIQUID FORM AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2768656C1 |
MEDICINAL FOR VAGINAL APPLICATION, WITH ANTIVIRAL, ANTIMICROBIAL, ANTIFUNGAL, ANTIPROTOZOAL, ANTIINFECTIOUS, IMMUNOMODULATING AND ANTIINFLAMMATORY ACTION, AS OINTMENT, GEL, SUPPOSITORY | 2016 |
|
RU2633056C1 |
ANTIVIRAL AGENT | 2000 |
|
RU2187330C1 |
CURATIVE AGENT | 2000 |
|
RU2187332C1 |
DRUG HERPFERON-2 POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANALGESIC ACTION FOR LOCAL AND EXTERNAL APPLICATION | 2012 |
|
RU2488405C1 |
RECOMBINANT PLASMID PFM-IFN-17 PROVIDING EXPRESSION OF INTERFERON ALPHA-2B OF HUMAN, RECOMBINANT PLASMID PFM-AP, PROVIDING EXPRESSION OF ENZYME METHIONINE-AMINOPEPTIDASE E COLI, BIPLASMID STRAIN ESCHERICHIA COLI FM-IFN-AP (PFM-IFN-17, PFM-AP) - PRODUCER (MET-) OF RECOMBINANT INTERFERON ALPHA -2B OF HUMAN | 2016 |
|
RU2610173C1 |
CYTOKINE-CONTAINING MEDICATION, POSSESSING ANTIVIRAL, ANTIMICROBIAL, IMMUNOMODULATING AND ANTI-INFLAMMATORY ACTION FOR PREVENTION AND TREATMENT OF INFECTION DISEASES | 2013 |
|
RU2554495C2 |
ANTIVIRAL AGENT - EYE DROPS | 2012 |
|
RU2473363C1 |
TABLETTED PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE FORMS OF VIRAL INFECTIONS | 2014 |
|
RU2559179C1 |
Authors
Dates
2019-05-27—Published
2018-11-27—Filed